Atrial fibrillation and risk of dementia/cognitive decline

Journal of Atrial Fibrillation

Volumn 8, Issue 5, 2016, Pages 53-60

  Shah, Anand D ^a   Merchant, Faisal M ^a   Delurgio, David B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Atrial fibrillation; Catheter ablation; Cognitive decline; Dementia

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ATORVASTATIN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ANTICOAGULANT THERAPY; ATRIAL FIBRILLATION; BRAIN BLOOD FLOW; BRAIN PERFUSION; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; COMORBIDITY; DEMENTIA; DISEASE ASSOCIATION; HEART ATRIUM APPENDAGE; HEART OUTPUT; HUMAN; MULTIINFARCT DEMENTIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK ASSESSMENT; RISK FACTOR; VASCULITIS;

EID: 84975745681     PISSN: None     EISSN: 19416911     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH, Jr., Zheng ZJ, Forouzanfar MH, Naghavi M, Mensah GA, Ezzati M, Murray CJ. Worldwide epidemiology of atrial fibrillation: A global burden of disease 2010 study. Circulation 2014;129:837-847.
2. Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, Newton-Cheh C, Lubitz SA, Magnani JW, Ellinor PT, Seshadri S, Wolf PA, Vasan RS, Benjamin EJ, Levy D. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the framingham heart study: A cohort study. The Lancet 2015;386:154-162.
3. Mitchell SL. Clinical practice. Advanced dementia. N Engl J Med 2015;372:2533-2540.
4. Hugo J, Ganguli M. Dementia and cognitive impairment: Epidemiology, diagnosis, and treatment. Clin Geriatr Med 2014;30:421-442.
5. Greenberg DAA, Michael J; Simon, Roger P. Clinical neurology. McGraw Hill; 2012.
6. Qiu C, Fratiglioni L. A major role for cardiovascular burden in age-related cognitive decline. Nat Rev Cardiol 2015;12:267-277.
7. Pendlebury STR, Peter M. Prevalence, incidence and factors associated with pre-stroke and post stroke-dementia: A systematic review and meta-analysis. Lancet Neurology 2009;8:1006-1018.
8. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S, American Heart Association Stroke Council CoE, Prevention CoCNCoCR, Intervention, Council on Cardiovascular S, Anesthesia. Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the american heart association/american stroke association. Stroke 2011;42:2672-2713.
9. Ott AB, Monique; de Bruyne, Martine; Van Harskamp, Frans; Grobbee, Diederick; Hofman, Albert. Atrial fibrillation and dementia in a population based study: The rotterdam study. Stroke 1997;28:316-321.
10. Thacker ELM, Barbara; Psaty, Bruce M, Longstreth, W. T.; Sitlani Colleen; Dublin, Sascha; Arnold, Alice M; Fitzpatrick, Annete L; Gottesman, Rebecca F, Heckbert, Susan R. Atrial fibrillation and cognitive decline. Neurology 2013;81:119-125.
11. Hui DS, Morley JE, Mikolajczak PC, Lee R. Atrial fibrillation: A major risk factor for cognitive decline. Am Heart J 2015;169:448-456.
12. Kalantarian SSTAM, Moussa; Ruskin, Jeremy N. Cognitive impairment associated with atrial fibrillation. Annals of Internal Medicine 2013;158:338-346.
13. Santangeli P, Di Biase L, Bai R, Mohanty S, Pump A, Cereceda Brantes M, Horton R, Burkhardt JD, Lakkireddy D, Reddy YM, Casella M, Dello Russo A, Tondo C, Natale A. Atrial fibrillation and the risk of incident dementia: A meta-analysis. Heart Rhythm 2012;9:1761-1768.
14. Rusanen M, Kivipelto M, Levalahti E, Laatikainen T, Tuomilehto J, Soininen H, Ngandu T. Heart diseases and long-term risk of dementia and alzheimer's disease: A population-based caide study. J Alzheimers Dis 2014;42:183-191.
15. Bunch TJ, Weiss JP, Crandall BG, May HT, Bair TL, Osborn JS, Anderson JL, Muhlestein JB, Horne BD, Lappe DL, Day JD. Atrial fibrillation is independently associated with senile, vascular, and alzheimer's dementia. Heart Rhythm 2010;7:433-437.
16. Mellon L, Brewer L, Hall P, Horgan F, Williams D, Hickey A, group A-Ss. Cognitive impairment six months after ischaemic stroke: A profile from the aspire-s study. BMC Neurol 2015;15:31.
17. Kokmen EW, J. P.; O'Fallon, W. M.; Chu, C-P; Beard, C. M. Dementia after ischemic stroke: A population based study in rochester, minnesota (1960-1984). Neurology 1996;19:154-159.
18. Ivan CS, Seshadri S, Beiser A, Au R, Kase CS, Kelly-Hayes M, Wolf PA. Dementia after stroke: The framingham study. Stroke 2004;35:1264-1268.
19. Kwok CSL, Y. K., Hale, R.; Potter, J. F.; Myint, P. K. Atrial fibrillation and incidence of dementia. Neurology 2011;76:914-922.
20. Bellomo A, De Benedetto G, Fossati C, D'Ottavio E, Formosa V, Gianturco V, Iori A, Marigliano B, Lo Iacono C, Troisi G, Marigliano V. Atrial fibrillation (af) and cognitive impairment in the elderly: A case-control study. Arch Gerontol Geriatr 2012;55:247-250.
21. Chen LY, Lopez FL, Gottesman RF, Huxley RR, Agarwal SK, Loehr L, Mosley T, Alonso A. Atrial fibrillation and cognitive decline-the role of subclinical cerebral infarcts: The atherosclerosis risk in communities study. Stroke 2014;45:2568-2574.
22. Vermeer SELJ, William T; Koudstaal, Peter J. Silent brain infarcts: A systematic review. The Lancet Neurology 2007;6:611-619.
23. Cermakova P, Eriksdotter M, Lund LH, Winblad B, Religa P, Religa D. Heart failure and alzheimer's disease. J Intern Med 2015;277:406-425.
24. de la Torre JC. Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia. Cardiovasc Psychiatry Neurol 2012;2012:367516.
25. Jefferson AL, Beiser AS, Himali JJ, Seshadri S, O'Donnell CJ, Manning WJ, Wolf PA, Au R, Benjamin EJ. Low cardiac index is associated with incident dementia and alzheimer disease: The framingham heart study. Circulation 2015;131:1333-1339.
26. Paulson OB, Hasselbalch SG, Rostrup E, Knudsen GM, Pelligrino D. Cerebral blood flow response to functional activation. J Cereb Blood Flow Metab 2010;30:2-14.
27. Abete P, Della-Morte D, Gargiulo G, Basile C, Langellotto A, Galizia G, Testa G, Canonico V, Bonaduce D, Cacciatore F. Cognitive impairment and cardiovascular diseases in the elderly. A heart-brain continuum hypothesis. Ageing Res Rev 2014;18:41-52.
28. Mosconi LdS, Susan; Li, Yi; Li, Juan; Zhan, Jiong; Tsui, Wai Hon; Boppana, Madhu; Pupi, Alberto; De Leon, Mony J. Visual rating of medial temporal lobe metabolism in mild cognitive impairment and alzheimer's disease using fdg-pet. European Journal of Nuclear Medicine and Molecular Imaging 2006;33:210-221.
29. Liu FG-I, Inge; Igbal, Khalid; Gong, Cheng-Xin. Contributions of protein phosphatases ppi, pp2a, pp2b, and pp5 to the regulation of tau phosphorylation. European Journal of Neuroscience 2005;22:1942-1950.
30. Bell RDZ, B. V. Neurovascular mechanisms and blood brain barrier disorder in alzheimer's disease. Acta Neuropathologica 2009;118:103-113.
31. Alosco ML, Spitznagel MB, Sweet LH, Josephson R, Hughes J, Gunstad J. Atrial fibrillation exacerbates cognitive dysfunction and cerebral perfusion in heart failure. Pacing Clin Electrophysiol 2015;38:178-186.
32. Kilander LA, Bertil; Nyman, Hakan; Lind, Lars; Boberg, Merike; Lithell, Hans. Atrial fibrillation is an independent determinant of low cognitive function. Stroke 1998;29:1816-1820.
33. Cacciatore F, Testa G, Langellotto A, Galizia G, Della-Morte D, Gargiulo G, Bevilacqua A, Del Genio MT, Canonico V, Rengo F, Abete P. Role of ventricular rate response on dementia in cognitively impaired elderly subjects with atrial fibrillation: A 10-year study. Dement Geriatr Cogn Disord 2012;34:143-148.
34. Wyse DGW, A. L.; DiMarco, J. P.; Domanski, M. J.; Rosenberg, Y.; Schron, E. B.; Kellen, J. C.; Greene, H. L.; Mickel, M. C.; Dalquist, J. E.; Corley, S. D.. A comparison of rate control and rhythm control in patient with atrial fibrillation. The New England Journal of Medicine 2002;347:1825-1833.
35. Chung MK, Shemanski L, Sherman DG, Greene HL, Hogan DB, Kellen JC, Kim SG, Martin LW, Rosenberg Y, Wyse DG, Investigators A. Functional status in rate- versus rhythm-control strategies for atrial fibrillation: Results of the atrial fibrillation follow-up investigation of rhythm management (affirm) functional status substudy. J Am Coll Cardiol 2005;46:1891-1899.
36. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WST, Hampel H, Hull M, Landreth G, Lue LF, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T. Inflammation and alzheimer's disease. Neurobiology of Aging;21:383-421.
37. Guo Y, Lip GY, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol 2012;60:2263-2270.
38. Parashar S, Kella D, Reid KJ, Spertus JA, Tang F, Langberg J, Vaccarino V, Kontos MC, Lopes RD, Lloyd MS. New-onset atrial fibrillation after acute myocardial infarction and its relation to admission biomarkers (from the triumph registry). Am J Cardiol 2013;112:1390-1395.
39. Yao SY, Chu JM, Chen KP, Tang M, Fang PH, Wang FZ, Zhang S. Inflammation in lone atrial fibrillation. Clin Cardiol 2009;32:94-98.
40. Takeda S, Sato N, Morishita R. Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in alzheimer disease: Relevance to pathogenesis and therapy. Front Aging Neurosci 2014;6:171.
41. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JJC, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW. 2014 aha/acc/hrs guideline for the management of patients with atrial fibrillation: Executive summarya report of the american college of cardiology/american heart association task force on practice guidelines and the heart rhythm society. Journal of the American College of Cardiology 2014;64:2246-2280.
42. Jacobs V, Woller SC, Stevens S, May HT, Bair TL, Anderson JL, Crandall BG, Day JD, Johanning K, Long Y, Mallender C, Olson JL, Osborn JS, Weiss JP, Bunch TJ. Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia. Heart Rhythm 2014;11:2206-2213.
43. Verheugt FWG, Christopher B. Oral anticoagulants for stroke prevention in atrial fibrillation: Current status, special situations and unmet needs. The Lancet 2015;386:303-310.
44. Li D-qZ, Yu-ping; Yang, Han. Donepezil combined with natural hirudin improves the clinical symptoms of patients with mild to moderate alzheimer's disease: A 20-week open-label pilot study. International Journal of Medical Sciences 2012;9:248-255.
45. Grammas PM, Joseph M. Targeting thrombin: An inflammatory neurotoxin in alzheimer's disease. Journal of Alzheimer's Disease 2014;42:S537-S544.
46. Sirtori CR. The pharmacology of statins. Pharmacological Research 2014;88:3-11.
47. Pena JM, MacFadyen J, Glynn RJ, Ridker PM. High-sensitivity c-reactive protein, statin therapy, and risks of atrial fibrillation: An exploratory analysis of the jupiter trial. Eur Heart J 2012;33:531-537.
48. Chao TF, Liu CJ, Chen SJ, Wang KL, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chen TJ, Lip GY, Chiang CE, Chen SA. Statins and the risk of dementia in patients with atrial fibrillation: A nationwide population-based cohort study. Int J Cardiol 2015;196:91-97.
49. Tendolkar I, Enajat M, Zwiers MP, van Wingen G, de Leeuw FE, van Kuilenburg J, Bouwels L, Pop G, Pop-Purceleanu M. One-year cholesterol lowering treatment reduces medial temporal lobe atrophy and memory decline in stroke-free elderly with atrial fibrillation: Evidence from a parallel group randomized trial. Int J Geriatr Psychiatry 2012;27:49-58.
50. Lappegard KTP-P, Monica; Van Heerde, Waander; Sexton, Joe; Tendolkar, Indira; Pop, Gheorghe. Improved neurocognitive functions correlate with reduced inflammator burden in atrial fibrillation patients treated with intensive cholesterol lowering therapy. Journal of Neuroinflammation 2013;10:78-84.
51. Marzona IOD, Martin; Teo, Koon; Gao, Peggy; Anderson, Craig; Bosch, Jackie; Yusuf, Salim. Increased risk of cognitive and functional decline in patients with atrial fibrillation: Results of the ontarger and transcend studies. Canadian Medical Association Journal 2012;184.
52. Calkins H, Reynolds MR, Spector P, Sondhi M, Xu Y, Martin A, Williams CJ, Sledge I. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: Two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol 2009;2:349-361.
53. Morillo CA, Verma A, Connolly SJ, Kuck KH, Nair GM, Champagne J, Sterns LD, Beresh H, Healey JS, Natale A, Investigators R-. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (raaft-2): A randomized trial. JAMA : the journal of the American Medical Association 2014;311:692-700.
54. Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W, Bash D, Schweikert R, Brachmann J, Gunther J, Gutleben K, Pisano E, Potenza D, Fanelli R, Raviele A, Themistoclakis S, Rossillo A, Bonso A, Natale A. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: A randomized trial. JAMA : the journal of the American Medical Association 2005;293:2634-2640.
55. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G, Natale A, Packer D, Skanes A, Ambrogi F, Biganzoli E. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010;3:32-38.
56. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G, Packer D, Skanes A. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005;111:1100-1105.
57. Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Horton R, Gallinghouse GJ, Lakkireddy D, Verma A, Khaykin Y, Hongo R, Hao S, Beheiry S, Pelargonio G, Dello Russo A, Casella M, Santarelli P, Santangeli P, Wang P, Al-Ahmad A, Patel D, Themistoclakis S, Bonso A, Rossillo A, Corrado A, Raviele A, Cummings JE, Schweikert RA, Lewis WR, Natale A. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: The impact of periprocedural therapeutic international normalized ratio. Circulation 2010;121:2550-2556.
58. Patel D, Bailey SM, Furlan AJ, Ching M, Zachaib J, Di Biase L, Mohanty P, Horton RP, Burkhardt JD, Sanchez JE, Zagrodzky JD, Gallinghouse GJ, Schweikert R, Saliba W, Natale A. Long-term functional and neurocognitive recovery in patients who had an acute cerebrovascular event secondary to catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol 2010;21:412-417.
59. Medi C, Evered L, Silbert B, Teh A, Halloran K, Morton J, Kistler P, Kalman J. Subtle post-procedural cognitive dysfunction after atrial fibrillation ablation. J Am Coll Cardiol 2013;62:531-539.
60. Merchant FM, Delurgio DB. Catheter ablation of atrial fibrillation and risk of asymptomatic cerebral embolism. Pacing Clin Electrophysiol 2014;37:389-397.
61. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215-1222.
62. Bunch TJ, Crandall BG, Weiss JP, May HT, Bair TL, Osborn JS, Anderson JL, Muhlestein JB, Horne BD, Lappe DL, Day JD. Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation. J Cardiovasc Electrophysiol 2011;22:839-845.
63. Hunter RJ, McCready J, Diab I, Page SP, Finlay M, Richmond L, French A, Earley MJ, Sporton S, Jones M, Joseph JP, Bashir Y, Betts TR, Thomas G, Staniforth A, Lee G, Kistler P, Rajappan K, Chow A, Schilling RJ. Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death. Heart 2012;98:48-53.
64. Blackshear JLO, J A. Appendage obliteration to reduce stroke in cardiac surgery patients with atrial fibrillation. Annals of Thoracic Surgery 1996;61:755-759.
65. Reddy VY, Doshi SK, Sievert H, Buchbinder M, Neuzil P, Huber K, Halperin JL, Holmes D, Investigators PA. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the protect af (watchman left atrial appendage system for embolic protection in patients with atrial fibrillation) trial. Circulation 2013;127:720-729.
66. Reddy VYS, H; Halperin, J; Doshi, S K; Buchbinder, M; Neuzil, P; Huber, K; Whisenant, B; Kar, S; Swarup, V; Gordon, N; Holmes, D. Percutanous left atrial appendage closure vs warfarin for atrial fibrillation. Journal of the American Medical Association 2014;312:1988-1998.